A trial in Italy that's testing Avextra’s cannabis-based medicine for ALS and other neurodegenerative diseases enrolled its ...

Former Texas A&M football player Chris Larkin will lead the Aggieland Against ALS festival to raise funds for ALS research.

People with ALS in the U.S. spend over $47,000 for medical care in the year after diagnosis, more than 3.5 times the average ...

Columnist Kristin Neva compares how ALS affects various parts of your identity, whether you're a patient or a caregiver.

Despite the inaccessibility of an "accessible" bathroom stall, columnist Dagmar Munn finds the humor in the situation.

A new dashboard by the ALS Association offers free and open access to real-world data from more than 4,000 people affected by ...

Columnist Dagmar Munn says her ALS diagnosis unexpectedly changed her mental clock. Every second of life became significant, she says.

Bristol Myers Squibb have extended their research collaboration aimed at designing and optimizing small-molecule drugs for ...

Researchers have identified new blood and spinal fluid biomarkers that could help track ALS progression and monitor treatment ...

ALS is more common in some parts of the U.S. than others and it has a very strong geographic association with MS, a new study ...

Living with ALS has taken a toll, but columnist Kristin Neva feels like she is doing better now than she has in a long time.

Researchers developed a cell-free DNA blood test that accurately distinguishes ALS from other neurological diseases and tracks progression.